Fig. 2 Effect of IPD-1151T, LMS, and N-5' on IgM-PFC and IgG-PFC formation in mice immunized with SRBC. Drugs were given p.o. for 5 days from the day of immunization. Each point represents the mean ± S.E. of 7 animals. (A): IgM-PFC formation (IgM-PFC/spleen), (B): IgM-PFC formation (IgM-PFC/106 spleen cells), (C): IgG PFC formation (IgG-PFC/spleen), (D): IgG-PFC formation (IgG-PFC/106 spleen cells), 0: Control; 0: IPD-l 151 T, 10 mg/kg; A: IPD-1151T, 20 mg/kg; A: IPD-1151T, 50 mg/kg; LI: IPD-1151T, 100 mg/kg; •: LMS, 20 mg/kg; V: N-5', 100 mg/kg. *J: Statistically significant difference from the control at P
[Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice].
We examined the effects of suplatast tosilate (IPD-1151T) on antibody formation in mice, and the following results were obtained: 1) IPD-1151T clearly...